Market Overview:
The global umifenovir market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of viral infections, increasing demand for antiviral drugs, and growing awareness about umifenovir. The global umifenovir market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into tablet, capsule, and others. The tablet segment is expected to account for a major share in terms of revenue in 2018 owing to its high adoption rate across regions. On the basis of application, hospitals are estimated to account for a major share in terms of revenue in 2018 owing to their large patient population base and increasing demand for antiviral drugs.
Product Definition:
Umifenovir is a drug used to prevent and treat influenza A and B viruses. It is a neuraminidase inhibitor.
Tablet:
Tablet is a portable device that can be used to consume medicines. It's major applications are in the pharmaceutical industry and medical field. The tablet is available in different forms such as hard, soft, and liquid-based on the ingredients it contains. Tablets are easy to swallow owing to their size and shape which helps deliver the medicine precisely where it needs to go without being absorbed by other tissues or fluids in the gastrointestinal tract.
Capsule:
Capsule is a small package containing drug substance and the delivery vehicle. The size of capsule can vary from one another as well as according to the dosage form. Capsules are widely used in pharmaceuticals industry owing to properties such as controlled release, high bioavailability, and targeted delivery among others.
Application Insights:
Based on the application, the global market is segmented into hospital, clinics, drug store and others. The hospital was estimated as the largest application segment in 2017 owing to its high usage rate for various indications such as respiratory infections, chickenpox and shingles. Umifenovir is also available without a prescription in some countries like India which further boosts its demand from hospitals.
The use of umifenovir has increased significantly due to development of self-injection kits which are used by individuals suffering from HIV/AIDS for their own treatment at home without medical assistance or supervision. Furthermore, increasing awareness about these self-injection kits among individuals who have no access to advanced healthcare facilities will boost market growth over the forecast period. UmiPharm International Inc., Mylan N.V.
Regional Analysis:
North America dominated the global market in 2017. The presence of key pharmaceutical and biopharmaceutical companies, advanced healthcare infrastructure, high patient awareness levels coupled with relatively higher healthcare spending in this region are some major factors responsible for its large share. Moreover, increasing government initiatives to combat the COVID-19 pandemic is expected to drive growth over the forecast period. For instance, on 10th September 2018; FDA released a public health emergency directive that authorizes staff to take necessary steps to respond to emergencies and protect public health without prior approval from headquarters. This action was taken after several recommendations made by Dr Scott Gottlieb, Commissioner of Food and Drugs Administration (FDA).
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing their rapidly improving healthcare systems along with rising investment by governments in developing countries such as China & India & others like Thailand Indonesia Philippines South Korea Vietnam Myanmar Australia New Zealand etc.
Growth Factors:
- Increasing prevalence of respiratory infections: The global incidence of respiratory infections is increasing due to the changing lifestyle and environmental conditions. This is expected to drive the demand for umifenovir in the coming years.
- Growing awareness about antiviral drugs: There is a growing awareness among people about the benefits of using antiviral drugs for treating various diseases, including respiratory infections. This is likely to boost the demand for umifenovir in the near future.
- Rising number of clinical studies on umifenovir: A large number of clinical studies are being conducted on umifenovir across the world, which is expected to create new opportunities for this drug in the coming years.
- Increasing use of combination therapies: Umifenovir is increasingly being used as a part of combination therapies for treating various diseases, including respiratory infections. This trend is likely to continue in future, resulting in higher demand for this drug worldwide.. 5
Scope Of The Report
Report Attributes
Report Details
Report Title
Umifenovir Market Research Report
By Type
Tablet, Capsule, Others
By Application
Hospital, Clinics, Drug Store, Others
By Companies
JSC Pharmstandard, Shandong Chuangxin Pharmaceutical Research and Development Co.,LTD, Yichang Tianren Pharmaceutical Co.,Ltd, Shenyang Coupling Biomedical Technology Co., Ltd.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Umifenovir Market Report Segments:
The global Umifenovir market is segmented on the basis of:
Types
Tablet, Capsule, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinics, Drug Store, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- JSC Pharmstandard
- Shandong Chuangxin Pharmaceutical Research and Development Co.,LTD
- Yichang Tianren Pharmaceutical Co.,Ltd
- Shenyang Coupling Biomedical Technology Co., Ltd.
Highlights of The Umifenovir Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tablet
- Capsule
- Others
- By Application:
- Hospital
- Clinics
- Drug Store
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Umifenovir Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Umifenovir is an antiviral medication used to treat infections caused by the human immunodeficiency virus (HIV). Umifenovir works by blocking the replication of HIV in cells.
Some of the major companies in the umifenovir market are JSC Pharmstandard, Shandong Chuangxin Pharmaceutical Research and Development Co.,LTD, Yichang Tianren Pharmaceutical Co.,Ltd, Shenyang Coupling Biomedical Technology Co., Ltd..
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Umifenovir Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Umifenovir Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Umifenovir Market - Supply Chain
4.5. Global Umifenovir Market Forecast
4.5.1. Umifenovir Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Umifenovir Market Size (000 Units) and Y-o-Y Growth
4.5.3. Umifenovir Market Absolute $ Opportunity
5. Global Umifenovir Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Umifenovir Market Size and Volume Forecast by Type
5.3.1. Tablet
5.3.2. Capsule
5.3.3. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Umifenovir Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Umifenovir Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Clinics
6.3.3. Drug Store
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Umifenovir Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Umifenovir Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Umifenovir Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Umifenovir Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Umifenovir Demand Share Forecast, 2019-2026
9. North America Umifenovir Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Umifenovir Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Umifenovir Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Clinics
9.4.3. Drug Store
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Umifenovir Market Size and Volume Forecast by Type
9.7.1. Tablet
9.7.2. Capsule
9.7.3. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Umifenovir Demand Share Forecast, 2019-2026
10. Latin America Umifenovir Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Umifenovir Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Umifenovir Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Clinics
10.4.3. Drug Store
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Umifenovir Market Size and Volume Forecast by Type
10.7.1. Tablet
10.7.2. Capsule
10.7.3. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Umifenovir Demand Share Forecast, 2019-2026
11. Europe Umifenovir Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Umifenovir Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Umifenovir Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Clinics
11.4.3. Drug Store
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Umifenovir Market Size and Volume Forecast by Type
11.7.1. Tablet
11.7.2. Capsule
11.7.3. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Umifenovir Demand Share, 2019-2026
12. Asia Pacific Umifenovir Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Umifenovir Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Umifenovir Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Clinics
12.4.3. Drug Store
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Umifenovir Market Size and Volume Forecast by Type
12.7.1. Tablet
12.7.2. Capsule
12.7.3. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Umifenovir Demand Share, 2019-2026
13. Middle East & Africa Umifenovir Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Umifenovir Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Umifenovir Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Clinics
13.4.3. Drug Store
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Umifenovir Market Size and Volume Forecast by Type
13.7.1. Tablet
13.7.2. Capsule
13.7.3. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Umifenovir Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Umifenovir Market: Market Share Analysis
14.2. Umifenovir Distributors and Customers
14.3. Umifenovir Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. JSC Pharmstandard
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Shandong Chuangxin Pharmaceutical Research and Development Co.,LTD
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Yichang Tianren Pharmaceutical Co.,Ltd
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Shenyang Coupling Biomedical Technology Co., Ltd.
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
